Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Taysha Gene Therapies, Inc. (TSHA) had Debt to Capital Ratio of 0.11 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-46.64M |
|
-- |
|
-- |
|
$47.35M |
|
$-47.35M |
|
$0.71M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-47.35M |
|
$-47.06M |
|
369.04M |
|
369.04M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$461.43M |
|
$2.41M |
|
$9.00M |
|
$470.43M |
|
$25.98M |
|
$49.26M |
|
$57.19M |
|
$83.17M |
|
$387.27M |
|
$387.27M |
|
$387.27M |
|
325.30M |
|
| Cash Flow Statement Financials | |
$-81.30M |
|
$-3.02M |
|
$217.37M |
|
$322.53M |
|
$455.57M |
|
$133.04M |
|
$11.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.76 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.11 |
0.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.04% |
|
-12.04% |
|
-9.91% |
|
-10.68% |
|
$1.19 |
|
$-0.22 |
|
$-0.22 |
|